Pharmaco-Economic Evaluation of the Treatment used in Ophthalmological Practice
Keywords:
pharmacoeconomic evaluation, ophthalmology, medicines, relative risk, probabilities of events, cost-effectiveness analysis
Abstract
The most important among the clinical forms of glaucoma is primary open-angle glaucoma (POAG), which, according to various authors, occurs in 70%-92% of cases. Due to the high prevalence of POAG, late detection and serious prognosis for visual functions, this disease occupies a special place in clinical ophthalmology. The aim of the study is to conduct a pharmacoeconomic evaluation of Tafluprostvs Travoprost in patients with POAG. Materials and methods of research is pharmacoeconomic methods of analysis, in particular the calculation of the relative risk, the calculation of the probability of events, cost-effectiveness analysis. According to the calculated results of pharmacoeconomic analyzes, Tafluprost was relatively less expensive and more clinically effective than Travoprost in patients with primary open-angle glaucoma. Alternative treatment with Tafluprost contributes to savings in the overall treatment procedure. Therefore, we recommend adding Tafluprost to the list of essential medicines.
Downloads
How to Cite
References
S Djalalov, Ch, D Djalalova, Kh, D Khoch (2012) The role of systematic review and meta-analysis in the evaluation of technologies in health care. (3), 10-15.
Kenji Inoue, Ayumi Tanaka, Goji Tomita (2013) Effects of tafluprost treatment for 3 years in patients with normal-tension glaucoma. 7, 1411.
Iwasa Inoue, Tomita Wakakura Effects of Travoprost treatment for 3 years in patients with 4. Brown GC and Brown MM (2019) Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma.
Nice (2017) Glaucoma: Diagnosis and management.
S Djalalov, Ch, D Djalalova, Kh, D Khoch (2014) Conceptualization of a model for medical technology assessment. (2), 18-20.
S Djalalov, D Djalalova, M Krahn, N Matveev, J Hoch (2020) PCN252 QUALITY EVALUATION OF PHARMACOECONOMIC STUDIES IN RUSSIAN CANCER RESEARCH: AN OUTSIDE VIEW. 22, S104.
David Rein (2006) The Economic Burden of Major Adult Visual Disorders in the United States. 124(12), 1754.
P Lichter (2001) Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. 108(11), 1943-1953.
A Heijl (2002) Reduction of Intraocular Pressure and Glaucoma Progression. 120(10), 12-68.
Nice (2009) A new guideline to improve the diagnosis and management of chronic open angle glaucoma and ocular hypertension in the UK will be available from April 22. 577(1), 3-3.
Bryan Lee, Steven Kymes, Robert Nease, Walton Sumner, Carla Siegfried, Mae Gordon (2008) The Impact of Anchor Point on Utilities for 5 Common Ophthalmic Diseases. 115(5), 898-903.e4.
Ricardo Paletta Guedes, Vanessa Paletta Guedes, Sirley Freitas, Alfredo Chaoubah (2015) Does the type of treatment have an influence on utility values in a glaucoma population?. 1645.
Vivek Adwe, Khurshed Bharucha, Atul Hegade, Rahul Deshpande, Madan Deshpande, Vk Kalyani (2016) Evaluation of skills transfer in short-term phacoemulsification surgery training program by International Council of Ophthalmology -Ophthalmology Surgical Competency Assessment Rubrics (ICO-OSCAR) and assessment of efficacy of ICO-OSCAR for objective evaluation of skills transfer. 68(8), 1573.
A Liberati, D Altman, J Tetzlaff, C Mulrow, P Gotzsche, J Ioannidis, M Clarke, P Devereaux, J Kleijnen, D Moher (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. 339(jul21 1), b2700-b2700.
Published
2022-07-09
Issue
Section
License
Copyright (c) 2022 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.